Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 8-K Event Shareholder vote results
  4. DEFA14A Proxy Proxy Materials
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. DEFA14A Proxy Proxy Materials
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. ARS Other Annual Report to Security Holders
  13. DEF 14A Proxy Proxy Statement
  14. DEFA14A Proxy Proxy Materials
  15. PRE 14A Proxy Proxy Statement (Preliminary)
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 8-K Event Other events
  20. 424B5 Offering Prospectus

Page 2 of 47 · 923 filings